vs

Side-by-side financial comparison of MSCI Inc. (MSCI) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $822.5M, roughly 1.7× MSCI Inc.). MSCI Inc. runs the higher net margin — 34.6% vs 27.6%, a 7.0% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 10.6%). Over the past eight quarters, MSCI Inc.'s revenue compounded faster (10.0% CAGR vs 7.9%).

MSCI Inc. is an American finance company headquartered in New York City. MSCI is a global provider of equity, fixed income, real estate indices, multi-asset portfolio analysis tools, ESG and climate finance products. It operates the MSCI World, MSCI Emerging Markets, and MSCI All Country World (ACWI) indices, among others.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

MSCI vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.7× larger
RMD
$1.4B
$822.5M
MSCI
Growing faster (revenue YoY)
RMD
RMD
+0.3% gap
RMD
11.0%
10.6%
MSCI
Higher net margin
MSCI
MSCI
7.0% more per $
MSCI
34.6%
27.6%
RMD
Faster 2-yr revenue CAGR
MSCI
MSCI
Annualised
MSCI
10.0%
7.9%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
MSCI
MSCI
RMD
RMD
Revenue
$822.5M
$1.4B
Net Profit
$284.7M
$392.6M
Gross Margin
61.8%
Operating Margin
56.4%
34.6%
Net Margin
34.6%
27.6%
Revenue YoY
10.6%
11.0%
Net Profit YoY
-6.8%
13.9%
EPS (diluted)
$3.81
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSCI
MSCI
RMD
RMD
Q2 26
$1.4B
Q4 25
$822.5M
$1.4B
Q3 25
$793.4M
$1.3B
Q2 25
$772.7M
$1.3B
Q1 25
$745.8M
$1.3B
Q4 24
$743.5M
$1.3B
Q3 24
$724.7M
$1.2B
Q2 24
$707.9M
$1.2B
Net Profit
MSCI
MSCI
RMD
RMD
Q2 26
$392.6M
Q4 25
$284.7M
$392.6M
Q3 25
$325.4M
$348.5M
Q2 25
$303.6M
$379.7M
Q1 25
$288.6M
$365.0M
Q4 24
$305.5M
$344.6M
Q3 24
$280.9M
$311.4M
Q2 24
$266.8M
$292.2M
Gross Margin
MSCI
MSCI
RMD
RMD
Q2 26
61.8%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Q2 24
58.5%
Operating Margin
MSCI
MSCI
RMD
RMD
Q2 26
34.6%
Q4 25
56.4%
34.6%
Q3 25
56.4%
33.4%
Q2 25
55.0%
33.7%
Q1 25
50.6%
33.0%
Q4 24
54.5%
32.5%
Q3 24
55.4%
31.6%
Q2 24
54.0%
31.2%
Net Margin
MSCI
MSCI
RMD
RMD
Q2 26
27.6%
Q4 25
34.6%
27.6%
Q3 25
41.0%
26.1%
Q2 25
39.3%
28.2%
Q1 25
38.7%
28.3%
Q4 24
41.1%
26.9%
Q3 24
38.8%
25.4%
Q2 24
37.7%
23.9%
EPS (diluted)
MSCI
MSCI
RMD
RMD
Q2 26
$2.68
Q4 25
$3.81
$2.68
Q3 25
$4.25
$2.37
Q2 25
$3.92
$2.58
Q1 25
$3.71
$2.48
Q4 24
$3.89
$2.34
Q3 24
$3.57
$2.11
Q2 24
$3.37
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSCI
MSCI
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$515.3M
$1.4B
Total DebtLower is stronger
$6.2B
$663.8M
Stockholders' EquityBook value
$-2.7B
$6.3B
Total Assets
$5.7B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSCI
MSCI
RMD
RMD
Q2 26
$1.4B
Q4 25
$515.3M
$1.4B
Q3 25
$400.1M
$1.4B
Q2 25
$347.3M
$1.2B
Q1 25
$360.7M
$932.7M
Q4 24
$409.4M
$521.9M
Q3 24
$501.0M
$426.4M
Q2 24
$451.4M
$238.4M
Total Debt
MSCI
MSCI
RMD
RMD
Q2 26
$663.8M
Q4 25
$6.2B
$403.9M
Q3 25
$5.5B
$408.7M
Q2 25
$4.5B
$658.4M
Q1 25
$4.5B
$663.1M
Q4 24
$4.5B
$662.9M
Q3 24
$4.5B
$667.6M
Q2 24
$4.5B
$697.3M
Stockholders' Equity
MSCI
MSCI
RMD
RMD
Q2 26
$6.3B
Q4 25
$-2.7B
$6.3B
Q3 25
$-1.9B
$6.1B
Q2 25
$-886.2M
$6.0B
Q1 25
$-958.6M
$5.5B
Q4 24
$-940.0M
$5.3B
Q3 24
$-751.0M
$5.2B
Q2 24
$-734.5M
$4.9B
Total Assets
MSCI
MSCI
RMD
RMD
Q2 26
$8.5B
Q4 25
$5.7B
$8.5B
Q3 25
$5.4B
$8.3B
Q2 25
$5.4B
$8.2B
Q1 25
$5.3B
$7.6B
Q4 24
$5.4B
$7.1B
Q3 24
$5.4B
$7.2B
Q2 24
$5.5B
$6.9B
Debt / Equity
MSCI
MSCI
RMD
RMD
Q2 26
0.11×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSCI
MSCI
RMD
RMD
Operating Cash FlowLast quarter
$501.1M
Free Cash FlowOCF − Capex
$488.7M
FCF MarginFCF / Revenue
59.4%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
1.76×
TTM Free Cash FlowTrailing 4 quarters
$1.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSCI
MSCI
RMD
RMD
Q2 26
Q4 25
$501.1M
$339.7M
Q3 25
$449.4M
$457.3M
Q2 25
$336.1M
$538.8M
Q1 25
$301.7M
$578.7M
Q4 24
$430.6M
$308.6M
Q3 24
$421.6M
$325.5M
Q2 24
$349.2M
$440.1M
Free Cash Flow
MSCI
MSCI
RMD
RMD
Q2 26
Q4 25
$488.7M
$311.2M
Q3 25
$445.5M
$414.4M
Q2 25
$324.7M
$508.2M
Q1 25
$290.2M
$557.9M
Q4 24
$416.4M
$288.0M
Q3 24
$415.0M
$307.7M
Q2 24
$340.6M
$415.2M
FCF Margin
MSCI
MSCI
RMD
RMD
Q2 26
Q4 25
59.4%
21.9%
Q3 25
56.2%
31.0%
Q2 25
42.0%
37.7%
Q1 25
38.9%
43.2%
Q4 24
56.0%
22.5%
Q3 24
57.3%
25.1%
Q2 24
48.1%
33.9%
Capex Intensity
MSCI
MSCI
RMD
RMD
Q2 26
Q4 25
1.5%
2.0%
Q3 25
0.5%
3.2%
Q2 25
1.5%
2.3%
Q1 25
1.5%
1.6%
Q4 24
1.9%
1.6%
Q3 24
0.9%
1.5%
Q2 24
1.2%
2.0%
Cash Conversion
MSCI
MSCI
RMD
RMD
Q2 26
Q4 25
1.76×
0.87×
Q3 25
1.38×
1.31×
Q2 25
1.11×
1.42×
Q1 25
1.05×
1.59×
Q4 24
1.41×
0.90×
Q3 24
1.50×
1.05×
Q2 24
1.31×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSCI
MSCI

Recurring Subscriptions$246.4M30%
Asset Based Fees$211.7M26%
Analytics Segment$182.3M22%
Sustainability And Climate Segment$90.3M11%
Other$70.9M9%
Non Recurring$21.1M3%

RMD
RMD

Segment breakdown not available.

Related Comparisons